Mural Oncology (MURA) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Mural Oncology

    NASDAQ: MURA · Real-Time Price · USD
    2.08
    0.00 (0.00%)
    At close: Oct 06, 2025, 10:12 AM

    Mural Oncology Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 115.46M 270.85M -19.39M -25.31M
    Short-Term Investments
    		 28.92M n/a n/a n/a
    Long-Term Investments
    		 n/a 258K n/a n/a
    Other Long-Term Assets
    		 1.98M n/a n/a n/a
    Receivables
    		 51K 5.55M n/a n/a
    Inventory
    		 n/a n/a n/a n/a
    Other Current Assets
    		 805K 787K 21.22M 27.34M
    Total Current Assets
    		 152.92M 277.34M 4.82M 4.24M
    Property-Plant & Equipment
    		 14.5M 24.15M 28.93M 30.87M
    Goodwill & Intangibles
    		 n/a n/a n/a n/a
    Total Long-Term Assets
    		 16.48M 24.41M 28.93M 30.87M
    Total Assets
    		 169.39M 301.75M 33.75M 35.11M
    Account Payables
    		 2.06M 5.97M 2.97M 10.59M
    Deferred Revenue
    		 n/a n/a n/a n/a
    Short-Term Debt
    		 5.56M 6.1M 5.84M 5.92M
    Other Current Liabilities
    		 13.02M 4.99M 19.8M 4.52M
    Total Current Liabilities
    		 26.2M 29.02M 41.56M 33.25M
    Long-Term Debt
    		 n/a n/a n/a n/a
    Other Long-Term Liabilities
    		 235K n/a 304K 356K
    Total Long-Term Liabilities
    		 2.7M 8.91M 13.85M 19.74M
    Total Liabilities
    		 28.89M 37.93M 55.41M 52.99M
    Total Debt
    		 8.02M 15.01M 19.39M 25.31M
    Book Value
    		 140.5M 263.82M -21.66M -17.88M
    Book Value Per Share
    		 8.29 15.81 -1.3 -1.07
    Common Stock
    		 171K 167K n/a n/a
    Retained Earnings
    		 -159.37M -30.86M n/a n/a
    Comprehensive Income
    		 n/a n/a -21.66M -17.88M
    Shareholders Equity
    		 140.5M 263.82M -21.66M -17.88M
    Total Investments
    		 28.92M 258K n/a n/a

    Add to Watchlist